🇫🇷 🇧🇪

Exit

Sector: Life Sciences
Fund: Club I
Team: Aurélien Valet

Description

Graftys is active in medtech’s market, is one of the world leaders in synthetic resorbable orthopaedic cements, with a pipeline of 2 marketed products (registered in 27 countries).

Following to the capital increase structured by TheClubDeal, Graftys has relocated its headquarters in Wallonia from France while refocusing its French unit (located in Aix-en-Provence) around its core cement production skills.

Company News

Graftys reprend la société française Biologics for Life

Graftys reprend la société française Biologics for Life

Read more

GOMET’S SANTE : Graftys (Aix) lève 4 millions et transfère son siège en Belgique

GOMET’S SANTE : Graftys (Aix) lève 4 millions et transfère son siège en Belgique

Read more

L’ECHO: L’écosystème biotech wallon séduit le champion français Graftys

L’ECHO: L’écosystème biotech wallon séduit le champion français Graftys

Read more

L’ECHO: Née en France, la biotech Graftys se relance au départ de la Wallonie

L’ECHO: Née en France, la biotech Graftys se relance au départ de la Wallonie

Read more

Investment Managers

Other investments in Life Sciences

Other investments in Club I

Subscribe to our Newsletter

We seek to customise the content to the segments we serve.

These are both fund investors and the entrepreneurs with whom we have created alliances.

We are happy to keep in touch.

TCD Form Template Style